Psychedelic Medicine’s Rise in 2019

Late March of 2019, a collection of European technology investors made waves in the psychedelic medicine industry, amassing the largest-ever private financing round for biotech company, ATAI Life Sciences (“ATAI”). According to ATAI’s press release, the German-based company’s Series B financing … Read more about Psychedelic Medicine’s Rise in 2019

Iowa Bill to Legalize Psilocybin Mushrooms and MDMA

In a surprising move late last week, Iowa Rep. Jeff Shipley (R) filed two pieces of legislation in the Iowa state legislature to legalize specific psychedelic substances as treatments. The first bill would approve the medical use of psilocybin, methylenedioxymethamphetamine (“MDMA”), and ibogaine – … Read more about Iowa Bill to Legalize Psilocybin Mushrooms and MDMA

Psilocybin Mushroom Initiative Makes Denver 2019 Ballot

Denver will be preparing for another major drug debate, as officials announced last Friday that the effort to decriminalize psilocybin mushroom has received enough signatures to make the upcoming May ballot. Local advocacy group, Decriminalize Denver, received over 5,000 signatures for the … Read more about Psilocybin Mushroom Initiative Makes Denver 2019 Ballot

Denver Mushroom Ballot Initiative

Colorado may soon have another opportunity to reform drug policy – this time, with psilocybin mushrooms. Activist group Decriminalize Denver has announced that they have gathered enough ballot petitions for the opportunity to vote on the decriminalization of psilocybin mushrooms in the upcoming May … Read more about Denver Mushroom Ballot Initiative